menu

Trimethylamine N-Oxide and CKD: A Concerning Link

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Trimethylamine N-Oxide and CKD: A Concerning Link

ReachMD Healthcare Image
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    Researchers from the Cleveland Clinic and Tufts University have uncovered that high levels of trimethylamine N-oxide (TMAO) may be a significant predictor of chronic kidney disease (CKD). By identifying TMAO as a potential predictive biomarker, this study paves the way for earlier detection and targeted interventions to mitigate the burden of CKD. Learn more with this recap of the study.

Facebook Comments

Recommended
Details
Comments
  • Overview

    Researchers from the Cleveland Clinic and Tufts University have uncovered that high levels of trimethylamine N-oxide (TMAO) may be a significant predictor of chronic kidney disease (CKD). By identifying TMAO as a potential predictive biomarker, this study paves the way for earlier detection and targeted interventions to mitigate the burden of CKD. Learn more with this recap of the study.

Facebook Comments

Schedule25 Jun 2024